Product NDC: | 68134-363 |
Proprietary Name: | Naproxen |
Non Proprietary Name: | Naproxen |
Active Ingredient(s): | 125 mg/5mL & nbsp; Naproxen |
Administration Route(s): | ORAL |
Dosage Form(s): | SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68134-363 |
Labeler Name: | Palmetto Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074190 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130625 |
Package NDC: | 68134-363-01 |
Package Description: | 500 mL in 1 BOTTLE, PLASTIC (68134-363-01) |
NDC Code | 68134-363-01 |
Proprietary Name | Naproxen |
Package Description | 500 mL in 1 BOTTLE, PLASTIC (68134-363-01) |
Product NDC | 68134-363 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Naproxen |
Dosage Form Name | SUSPENSION |
Route Name | ORAL |
Start Marketing Date | 20130625 |
Marketing Category Name | ANDA |
Labeler Name | Palmetto Pharmaceuticals |
Substance Name | NAPROXEN |
Strength Number | 125 |
Strength Unit | mg/5mL |
Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |